The Current Ratio as of September 2024 (TTM) for Shattuck Labs, Inc. (STTK) is 7.62

According to Shattuck Labs, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.62. This represents a change of -18.35% compared to the average of 9.33 of the last 4 quarters.

Shattuck Labs, Inc. (STTK) Historical Current Ratio (quarterly & annually)

How has STTK Current Ratio performed in the past?

The mean historical Current Ratio of Shattuck Labs, Inc. over the last ten years is 9.57. The current 7.62 Current Ratio has changed 7.86% with respect to the historical average. Over the past ten years (40 quarters), STTK's Current Ratio was at its highest in in the June 2021 quarter at 20.90. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Shattuck Labs, Inc. (STTK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Shattuck Labs, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shattuck Labs, Inc. (STTK) Average Current Ratio

How has STTK Current Ratio performed in the past?

The current Current Ratio of Shattuck Labs, Inc. (STTK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Shattuck Labs, Inc. (STTK) Current Ratio vs. Peers

How is STTK’s Current Ratio compared to its peers?

Shattuck Labs, Inc.’s Current Ratio is greater than C4 Therapeutics, Inc. (5.09), less than Eliem Therapeutics, Inc. (60.41), less than Prelude Therapeutics Incorporated (7.83), greater than Monte Rosa Therapeutics, Inc. (6.56), greater than Foghorn Therapeutics Inc. (5.69), less than Kymera Therapeutics, Inc. (8.45), greater than Nurix Therapeutics, Inc. (5.57), less than Pardes Biosciences, Inc. (81.72), greater than Champions Oncology, Inc. (0.69), less than Century Therapeutics, Inc. (10.62), less than PMV Pharmaceuticals, Inc. (19.22), greater than Stoke Therapeutics, Inc. (6.67),

Build a custom stock screener for Shattuck Labs, Inc. (STTK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shattuck Labs, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shattuck Labs, Inc. (STTK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shattuck Labs, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.